
We have developed a comprehensive portfolio of VEGF family proteins covering various species, iso...

As of April 1, 2026, the European Pharmacopoeia EP 2.6.7 (12.2) has officially come into effect, ...

Gruber et al. (2026) in their study “Targeted Delivery of a Potent STING Agonist Payload via an A...

ADC quality directly dictates clinical efficacy, patient safety, and batch-to-batch consistency—d...

In the complex landscape of monoclonal antibody (mAb) development, striking a balance between the...
[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: Switzerland Innovation Park Basel Area, Novartis Campus, Lichtstrasse 35, 4056 Basel
Email:order@acrobiosystems.com
Copyright © 2025 ACROBiosystems. All Rights Reserved




